GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance
Our research shows shopper priorities are evolving quickly and dramatically. GLP-1 drugs usually are taken for 6 to 12 months, with just over 48% of current weight-loss users staying on the medication for a full year, Circana said, adding that cost is the chief reason users stop taking GLP-1s
By boosting metabolism and increasing energy levels, B12 can help you stay active and burn calories more efficiently
[10] [11] However, it is important to recognise that clinical trials may not capture every possible side effect, particularly those that are rare or occur in specific subpopulations